Peerview Oncology

Precision Care in Gastric GEJ Cancer Molecular Screening and Immunotherapy Platforms 01:05:02
Precision Care in Gastric GEJ Cancer Molecular Screening and Immunotherapy Platforms PeerView Oncology 173 1 месяц назад
The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals 57:49
The Collaborative Benchmark for HCC: Critical Discussions Between IR–Oncology Professionals PeerView Oncology 502 9 месяцев назад
A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer 01:01:04
A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer PeerView Oncology 328 1 месяц назад
Elevating Therapeutic Innovation in HCC: Cutting-Edge Strategies Across Disease Settings 43:12
Elevating Therapeutic Innovation in HCC: Cutting-Edge Strategies Across Disease Settings PeerView Oncology 153 1 месяц назад
Candid Conversations on Modern Urothelial Cancer Management 01:32:29
Candid Conversations on Modern Urothelial Cancer Management PeerView Oncology 381 8 месяцев назад
Addressing Unmet Needs in DLBCL: Prognostic Assessment and Off-the-Shelf Immunotherapy Strategies 16:54
Addressing Unmet Needs in DLBCL: Prognostic Assessment and Off-the-Shelf Immunotherapy Strategies PeerView Oncology 118 55 лет назад
Watch Drs. Moore, O'Malley & Pothuri discuss #OvarianCancer updates #SGO2025 - bit.ly/GynOnc25Y 01:11:39
Watch Drs. Moore, O'Malley & Pothuri discuss #OvarianCancer updates #SGO2025 - bit.ly/GynOnc25Y PeerView Oncology 201 6 дней назад
Watch Drs. Lenz, Lonardi & Strickler discuss #ColorectalCancer updates from #GI25: bit.ly/CRC-SF25Y 01:47:36
Watch Drs. Lenz, Lonardi & Strickler discuss #ColorectalCancer updates from #GI25: bit.ly/CRC-SF25Y PeerView Oncology 299 1 месяц назад
BTK Inhibition as an MS Treatment Strategy 52:37
BTK Inhibition as an MS Treatment Strategy PeerView CME 28 1 день назад
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment 01:11:32
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment PeerView Oncology 574 1 год назад
Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer 59:12
Making Precision Decisions in High-Risk HR+, HER2- Metastatic Breast Cancer PeerView Oncology 528 6 месяцев назад
Hormonal Therapeutic Strategies for Prostate Cancer: Clinical Evidence and Practical Considerations 01:23:44
Hormonal Therapeutic Strategies for Prostate Cancer: Clinical Evidence and Practical Considerations PeerView Oncology 7,253 2 года назад
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer 01:32:31
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer PeerView Oncology 876 8 месяцев назад
Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer 01:24:52
Guiding Multifactorial Clinical Decisions in HR+, HER2- Breast Cancer PeerView Oncology 670 4 месяца назад
Watch Drs. Agarwal & Schoen discuss the latest #ProstateCancer updates - https://bit.ly/mCRPCY 01:03:45
Watch Drs. Agarwal & Schoen discuss the latest #ProstateCancer updates - https://bit.ly/mCRPCY PeerView Oncology 144 55 лет назад
Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options 01:29:10
Multidirectional HCC Tactics: Expert Guidance on Emerging Trends With Systemic Therapy Options PeerView Oncology 403 8 месяцев назад
Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine 01:06:30
Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine PeerView Oncology 164 5 месяцев назад
The Personalized Paradigm in CRC Care Emerging Evidence for Therapy Selection in Advanced Disease 01:38:09
The Personalized Paradigm in CRC Care Emerging Evidence for Therapy Selection in Advanced Disease PeerView Oncology 190 1 месяц назад
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers 01:03:39
Deep Insight Into Immuno-Oncology: Immunotherapy Pathways, Targets, and Biomarkers PeerView Oncology 80,825 4 года назад
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selection and Sequencing 01:08:55
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selection and Sequencing PeerView Oncology 189 55 лет назад

Сейчас ищут